SynthesisFrontiers in pharmacology2026
The rise and evolution of cancer mechanobiology: a bibliometric trajectory of three decades of research.
Synthesis in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A growing body of research indicates that mechanobiology plays a pivotal role in cancer pathogenesis and holds considerable therapeutic potential. However, a comprehensive bibliometric analysis of this interdisciplinary field is lacking, partly due to challenges in cross-database data integration. In this study, we aim to construct a systematic knowledge map of cancer mechanobiology to delineate its research progress, core structure, and emerging trends. Methods: In this study, we integrated 1,947 publications from the Web of Science (WoS) Core Collection and Scopus (1976-2025). To address cross-database heterogeneity, we developed a novel, customized, multi-stage data-standardization workflow combining a bespoke Python parsing engine with fuzzy string matching algorithms and manual verification. The unified dataset was analyzed using CiteSpace, VOSviewer, and Bibliometrix. Results: The United States and China are the most prolific countries, while the University of California system is the most productive institution. Valerie M. Weaver is the most published author, while Matthew J. Paszek is the most co-cited, indicating foundational influence. Cell is the most influential journal based on co-citation frequency. Keyword analysis reveals a thematic evolution from "extracellular matrix stiffness" and "mechanotransduction" to frontier areas such as "cancer immunotherapy" and "YAP signaling protein." Conclusion: In this study, we construct a comprehensive bibliometric map of cancer mechanobiology. Our findings elucidate the developmental trajectory and research hotspots of the field, providing a data-driven reference for future investigations, international collaborations, and clinical translation of physical oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.